An open label, randomized, flexible dose, 6-week clinical trial of the safety and efficacy of divalproex ER [valproate semisodium] vs quetiapine in the treatment of behavioral symptoms in the elderly with moderate to severe Alzheimer's dementia

Trial Profile

An open label, randomized, flexible dose, 6-week clinical trial of the safety and efficacy of divalproex ER [valproate semisodium] vs quetiapine in the treatment of behavioral symptoms in the elderly with moderate to severe Alzheimer's dementia

Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 29 May 2015

At a glance

  • Drugs Valproate semisodium (Primary) ; Quetiapine
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 May 2015 Status changed from discontinued to withdrawn prior to enrolment as reported by ClinicalTrials.gov
    • 05 Dec 2007 Status changed from initiated to discontinued.
    • 23 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top